Notably, the patient exhibited positive paraneoplastic antibodies and was diagnosed with estrogen receptor (ER)/progesterone receptor (PR) positive breast cancer, emphasizing the importance of excluding malignancy as a potential underlying cause. Here, ESR1 is linked to breast carcinoma.